Different pathophysiological processes involved in SAH are now known to be regulated by miRNAs, including endothelial dysfunction, dysregulation of vascular smooth muscle cells (VSMCs), the increase of sympathetic system activity, and alterations in renin-angiotensin-aldosterone system (RAAS) [41,42]. The gene discussed is REN; the disease is endothelial dysfunction.